About the grant

Clinical trials are important because they’re the primary means of developing new treatments and improving existing ones. Acceptance into a clinical trial can sometimes offer vital access to new drugs. While clinical trials can offer promising treatment options for blood cancer patients, significant hurdles exist, from limited availability and eligibility criteria to practical, financial and social barriers that prevent participation.

For this reason, we launched clinical improvement grants to support healthcare professionals in improving access and awareness to blood cancer clinical trials.

• Clinical improvement grants were awarded for up to £25,000 for projects to be completed by April 2026.
• 4 projects were funded that aimed to make clinical trials more accessible, inclusive, and easier to understand, especially for underserved communities.
• This grant round is now closed. To stay informed about future opportunities, join our healthcare professional network.

This work is kindly supported by the Oglesby Charitable Trust.